Literature DB >> 2899456

Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000-180,000 P-glycoprotein.

I Sugawara1, M Nakahama, H Hamada, T Tsuruo, S Mori.   

Abstract

A monoclonal antibody (MAb), MRK 16, specific to Adriamycin-resistant human myelogenous leukemia cell line K562, was used to examine whether the antigen molecules (P-glycoprotein) recognized by the MAb are present in the adrenals. The materials examined included 61 human adrenals and several cell lines. Immunohistochemical analysis revealed that almost all of the human adrenal specimens (59 out of 61) were stained positively with MAb MRK 16 and that the antigen was strongly expressed even in cases where anticancer agents had not been given. Immunoprecipitation showed that the Mr 170,000-180,000 glycoprotein was present in all of the adult adrenals but not in fetal and neonatal adrenals. Furthermore, fluorescence image analysis revealed that the P-glycoprotein was more strongly expressed in the cortex than in the medulla, showing a tendency to occur in cell clusters in the latter area. The cell lines derived from animal adrenals (SW-13, Y-1, and PC-12) showed no positive staining with MAb MRK 16. It is suggested that this glycoprotein may be related to maturation of the adrenal, in which it possibly plays a physiological role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899456

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 2.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

Review 3.  P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

Authors:  S Gupta
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 4.  Antibodies in the study of multiple drug resistance.

Authors:  Y Heike; T Tsuruo
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 5.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function.

Authors:  S Gupta; C H Kim; T Tsuruo; S Gollapudi
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

7.  Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.

Authors:  K Mizuno; Y Furuhashi; O Maeda; M Iwata; T Misawa; M Kawai; T Kano; Y Tomoda
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 8.  P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection.

Authors:  S Gupta; S Gollapudi
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

9.  P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.

Authors:  Winnie Y Kim; Leslie Z Benet
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

10.  Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

Authors:  C K van Kalken; H J Broxterman; H M Pinedo; N Feller; H Dekker; J Lankelma; G Giaccone
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.